Schizophrenia
|
0.330 |
AlteredExpression
|
disease |
BEFREE |
The mRNA expression level of an epigenetically regulated schizophrenia candidate gene GAD67 was strongly and negatively correlated with the mRNA expression levels of HDAC1, HDAC3 and HDAC4 levels.
|
17961987 |
2008 |
Schizophrenia
|
0.330 |
Biomarker
|
disease |
PSYGENET |
The mRNA expression level of an epigenetically regulated schizophrenia candidate gene GAD67 was strongly and negatively correlated with the mRNA expression levels of HDAC1, HDAC3 and HDAC4 levels.
|
17961987 |
2008 |
Schizophrenia
|
0.330 |
Biomarker
|
disease |
BEFREE |
The results suggest that HDAC3 and HDAC4 genes might play a role in the pathophysiology of schizophrenia in a Korean population.
|
20471694 |
2010 |
Schizophrenia
|
0.330 |
Biomarker
|
disease |
BEFREE |
In addition to novel GWS loci, we have identified a significant genetic correlation with schizophrenia and association of ASD with several neurodevelopmental-related genes such as <i>EXT1</i>, <i>ASTN2</i>, <i>MACROD2</i>, and <i>HDAC4.</i>
|
28540026 |
2017 |
Schizophrenia
|
0.330 |
Biomarker
|
disease |
PSYGENET |
The results suggest that HDAC3 and HDAC4 genes might play a role in the pathophysiology of schizophrenia in a Korean population.
|
20471694 |
2010 |
Malignant neoplasm of urinary bladder
|
0.320 |
Biomarker
|
disease |
BEFREE |
The results of our immunohistochemistry (IHC) staining studies further revealed a strong correlation between the over-expression of HDAC4 and increased bladder cancer occurrence (p < 0.001) as well as a marginal significance of increasing incidence of HDAC4 positivity seen with an increase in severity of bladder cancer (p = 0.08).
|
21507255 |
2011 |
Malignant neoplasm of urinary bladder
|
0.320 |
Biomarker
|
disease |
CTD_human |
The results of our immunohistochemistry (IHC) staining studies further revealed a strong correlation between the over-expression of HDAC4 and increased bladder cancer occurrence (p < 0.001) as well as a marginal significance of increasing incidence of HDAC4 positivity seen with an increase in severity of bladder cancer (p = 0.08).
|
21507255 |
2011 |
Malignant neoplasm of urinary bladder
|
0.320 |
AlteredExpression
|
disease |
BEFREE |
We also observed increased expression in Hdac4, -7, and -9 in commonly used BC mouse models.
|
31137849 |
2019 |
Bladder Neoplasm
|
0.320 |
Biomarker
|
disease |
CTD_human |
The results of our immunohistochemistry (IHC) staining studies further revealed a strong correlation between the over-expression of HDAC4 and increased bladder cancer occurrence (p < 0.001) as well as a marginal significance of increasing incidence of HDAC4 positivity seen with an increase in severity of bladder cancer (p = 0.08).
|
21507255 |
2011 |
Bladder Neoplasm
|
0.320 |
Biomarker
|
disease |
BEFREE |
The results of our immunohistochemistry (IHC) staining studies further revealed a strong correlation between the over-expression of HDAC4 and increased bladder cancer occurrence (p < 0.001) as well as a marginal significance of increasing incidence of HDAC4 positivity seen with an increase in severity of bladder cancer (p = 0.08).
|
21507255 |
2011 |
Bladder Neoplasm
|
0.320 |
AlteredExpression
|
disease |
BEFREE |
We also observed increased expression in Hdac4, -7, and -9 in commonly used BC mouse models.
|
31137849 |
2019 |
Mental Depression
|
0.310 |
Biomarker
|
disease |
PSYGENET |
In BPD, the expression of HDAC4 mRNA was increased only in a depressive state, and the expression of HDAC6 and -8 was decreased in both depressive and remissive states compared to controls, whereas the first-degree relatives did not show any significant alteration in expression levels.
|
19767015 |
2010 |
Mental Depression
|
0.310 |
AlteredExpression
|
disease |
BEFREE |
In BPD, the expression of HDAC4 mRNA was increased only in a depressive state, and the expression of HDAC6 and -8 was decreased in both depressive and remissive states compared to controls, whereas the first-degree relatives did not show any significant alteration in expression levels.
|
19767015 |
2010 |
Cocaine Abuse
|
0.300 |
Therapeutic
|
disease |
CTD_human |
Histone deacetylase 5 epigenetically controls behavioral adaptations to chronic emotional stimuli.
|
17988634 |
2007 |
Contact Dermatitis
|
0.300 |
Biomarker
|
disease |
CTD_human |
Genes specifically modulated in sensitized skins allow the detection of sensitizers in a reconstructed human skin model. Development of the SENS-IS assay.
|
25724174 |
2015 |
Profound Mental Retardation
|
0.300 |
Biomarker
|
disease |
CTD_human |
Haploinsufficiency of HDAC4 causes brachydactyly mental retardation syndrome, with brachydactyly type E, developmental delays, and behavioral problems.
|
20691407 |
2010 |
Familial primary pulmonary hypertension
|
0.300 |
Biomarker
|
disease |
CTD_human |
Histone deacetylation inhibition in pulmonary hypertension: therapeutic potential of valproic acid and suberoylanilide hydroxamic acid.
|
22711276 |
2012 |
Malignant mesothelioma
|
0.300 |
Biomarker
|
disease |
CTD_human |
MicroRNA and mRNA features of malignant pleural mesothelioma and benign asbestos-related pleural effusion.
|
25756049 |
2015 |
Cocaine Dependence
|
0.300 |
Therapeutic
|
disease |
CTD_human |
Histone deacetylase 5 epigenetically controls behavioral adaptations to chronic emotional stimuli.
|
17988634 |
2007 |
Mental deficiency
|
0.300 |
Biomarker
|
disease |
CTD_human |
Haploinsufficiency of HDAC4 causes brachydactyly mental retardation syndrome, with brachydactyly type E, developmental delays, and behavioral problems.
|
20691407 |
2010 |
PULMONARY HYPERTENSION, PRIMARY, DEXFENFLURAMINE-ASSOCIATED
|
0.300 |
Biomarker
|
disease |
CTD_human |
Histone deacetylation inhibition in pulmonary hypertension: therapeutic potential of valproic acid and suberoylanilide hydroxamic acid.
|
22711276 |
2012 |
Pulmonary Hypertension, Primary, Fenfluramine-Associated
|
0.300 |
Biomarker
|
disease |
CTD_human |
Histone deacetylation inhibition in pulmonary hypertension: therapeutic potential of valproic acid and suberoylanilide hydroxamic acid.
|
22711276 |
2012 |
Idiopathic pulmonary arterial hypertension
|
0.300 |
Biomarker
|
disease |
CTD_human |
Histone deacetylation inhibition in pulmonary hypertension: therapeutic potential of valproic acid and suberoylanilide hydroxamic acid.
|
22711276 |
2012 |
Pulmonary Hypertension, Primary, 1, With Hereditary Hemorrhagic Telangiectasia
|
0.300 |
Biomarker
|
disease |
CTD_human |
Histone deacetylation inhibition in pulmonary hypertension: therapeutic potential of valproic acid and suberoylanilide hydroxamic acid.
|
22711276 |
2012 |
Pulmonary Hypertension, Primary, 1
|
0.300 |
Biomarker
|
disease |
CTD_human |
Histone deacetylation inhibition in pulmonary hypertension: therapeutic potential of valproic acid and suberoylanilide hydroxamic acid.
|
22711276 |
2012 |